疑难病杂志
疑難病雜誌
의난병잡지
JOURNAL OF DIFFICULT AND COMPLICATED CASES
2014年
11期
1165-1167
,共3页
沈鑫%沈洪涛%李军荣%李圣华%王华梅%陈靖
瀋鑫%瀋洪濤%李軍榮%李聖華%王華梅%陳靖
침흠%침홍도%리군영%리골화%왕화매%진정
失眠症%参松养心胶囊%艾司唑仑
失眠癥%參鬆養心膠囊%艾司唑崙
실면증%삼송양심효낭%애사서륜
Insomnia%Shensongyangxin capsule%Estazolam
目的:观察参松养心胶囊辅治失眠症的临床疗效。方法将72例失眠症患者随机分为治疗组和对照组,各36例。2组患者均给予心理治疗和行为干预,在此基础上治疗组加服参松养心胶囊每次4粒,每天3次,疗程4周;早期辅以艾司唑仑每晚1 mg,疗程1周。对照组加服艾司唑仑每晚1 mg,疗程4周。观察治疗前后匹兹堡睡眠质量指数量表( PSQI)变化及临床疗效,并记录药物不良反应。结果2组治疗后PSQI总分均有改善,差异均有统计学意义( P <0(.05),且治疗组优于对照组( P <0.05)。治疗前和治疗后差值比较,治疗组在睡眠质量、入睡时间、睡眠时间、睡眠效率、催眠药物,日间功能改善方面优于对照组,差异有统计学意义( P <0.05),而睡眠障碍评分无显著差异( P >0.05)。疗程结束后治疗组总有效率为85.7%,高于照组的61.8%(χ2=5.130, P <0.05);治疗组不良反应发生率为57.%,对照组为38.2%,2组比较差异有统计学意义(χ2=10.72, P <0.01)。结论参松养心胶囊辅治失眠症安全而有效。
目的:觀察參鬆養心膠囊輔治失眠癥的臨床療效。方法將72例失眠癥患者隨機分為治療組和對照組,各36例。2組患者均給予心理治療和行為榦預,在此基礎上治療組加服參鬆養心膠囊每次4粒,每天3次,療程4週;早期輔以艾司唑崙每晚1 mg,療程1週。對照組加服艾司唑崙每晚1 mg,療程4週。觀察治療前後匹玆堡睡眠質量指數量錶( PSQI)變化及臨床療效,併記錄藥物不良反應。結果2組治療後PSQI總分均有改善,差異均有統計學意義( P <0(.05),且治療組優于對照組( P <0.05)。治療前和治療後差值比較,治療組在睡眠質量、入睡時間、睡眠時間、睡眠效率、催眠藥物,日間功能改善方麵優于對照組,差異有統計學意義( P <0.05),而睡眠障礙評分無顯著差異( P >0.05)。療程結束後治療組總有效率為85.7%,高于照組的61.8%(χ2=5.130, P <0.05);治療組不良反應髮生率為57.%,對照組為38.2%,2組比較差異有統計學意義(χ2=10.72, P <0.01)。結論參鬆養心膠囊輔治失眠癥安全而有效。
목적:관찰삼송양심효낭보치실면증적림상료효。방법장72례실면증환자수궤분위치료조화대조조,각36례。2조환자균급여심리치료화행위간예,재차기출상치료조가복삼송양심효낭매차4립,매천3차,료정4주;조기보이애사서륜매만1 mg,료정1주。대조조가복애사서륜매만1 mg,료정4주。관찰치료전후필자보수면질량지수량표( PSQI)변화급림상료효,병기록약물불량반응。결과2조치료후PSQI총분균유개선,차이균유통계학의의( P <0(.05),차치료조우우대조조( P <0.05)。치료전화치료후차치비교,치료조재수면질량、입수시간、수면시간、수면효솔、최면약물,일간공능개선방면우우대조조,차이유통계학의의( P <0.05),이수면장애평분무현저차이( P >0.05)。료정결속후치료조총유효솔위85.7%,고우조조적61.8%(χ2=5.130, P <0.05);치료조불량반응발생솔위57.%,대조조위38.2%,2조비교차이유통계학의의(χ2=10.72, P <0.01)。결론삼송양심효낭보치실면증안전이유효。
Objective To observe the therapeutic effect of Shensongyangxin capsule in the treatment of insomnia . Methods Seventy-two cases of insomnia were randomly divided into treatment group and control group , 36 cases in each group.2 groups of patients were given psychological therapy and behavior intervention , on the basis of this therapy , treatment group were treated with Shensongyangxin capsule with 4 capsules each time, 3 times a day, for 4 weeks;early time combined with estazolam every night , 1 mg, 1 week course of treatment .Control group took estazolam every night , 1 mg, 4 week course of treatment .The Pittsburgh sleep quality index ( PSQI ) changes and clinical curative effect , and the adverse drug reaction were observed before and after treatment .Results The total score of PSQI were improved in both groups after treatment , the difference was statistically significant ( P <0.05), and the treatment group better than in control group ( P <0.05).Com-pared the difference between before and after treatment , the treatment group’s sleep quality, sleep time, sleep time, sleep ef-ficiency , hypnotic medicaments , daytime function were better than the control group , the difference was statistically significant ( P <0.05), but there was no significant difference of the sleep disorder score ( P >0.05).After treatment, the total effec-tive rate of treatment group was 85.7%,higher than 61.8%in the control group (χ2 =5.130, P <0.05);treatment group’s incidence rate of adverse reaction was 5.7%, and control group was 38.2%, there was significant difference between the 2 groups (χ2 =10.72, P <0.01).Conclusion It demonstrated that the Shensongyangxin capsule in treatment of insomnia was safety and effective .